Strömblad S, Eriksson L C, Andersson G
Department of Pathology, Karolinska Institutet, Huddinge University Hospital, Sweden.
Mol Carcinog. 1994 Jun;10(2):97-104. doi: 10.1002/mc.2940100207.
The influence of the tumor promoter 2-acetylaminofluorene (2-AAF) on cell proliferation and on the epidermal growth factor receptor (EGFR) system was assessed in normal and nodular rat livers. DNA replication in vivo was inhibited below the detection level after 8d of dietary 2-AAF treatment of previously unexposed rats. The 2-AAF-induced growth inhibition was accompanied by downregulation of the number of epidermal growth factor (EGF)-binding sites and decreased levels of EGFR transcripts, whereas no changes in the transforming growth factor-alpha (TGF-alpha) mRNA levels were observed. The persistent liver nodules generated by intermittent 2-AAF-feeding had a 30- to 35-fold higher replicating cell fraction than normal liver. Treatment with 2-AAF in vivo reduced the replicating cell fraction to one third in nodules after 14 d of 2-AAF treatment. The initial EGFR mRNA levels and number of EGF binding sites in nodules before 2-AAF administration was about 605 that of control livers and was slightly reduced by 2-AAF feeding. The levels of EGFR mRNA after 14 d of 2-AAF feeding were thus similar in the nodules and in the 2-AAF-treated control livers, whereas the fraction of proliferating cells in nodules after the 2-AAF treatment was much larger than in normal liver. The TGF-alpha mRNA level in the nodules was found to be 1.4-fold and in malignant hepatomas 1.7-fold the level in normal liver. Primary hepatocytes isolated from control livers were four to five times more sensitive to replicative stimulation with EGF than with TGF-alpha, whereas nodular cells responded at lower concentrations than control cells and equally well to both EGF and TGF-alpha. We conclude that the decreased amounts of EGFR in the nodular cells with respect to proliferative stimulation could be more than compensated for by elevated synthesis of TGF-alpha combined with an increased TGF-alpha sensitivity. Collectively, these changes implicate TGF-alpha in sustaining cell proliferation during chemically induced rat liver carcinogenesis.
在正常和结节性大鼠肝脏中评估了肿瘤启动剂2-乙酰氨基芴(2-AAF)对细胞增殖及表皮生长因子受体(EGFR)系统的影响。对先前未接触过2-AAF的大鼠进行8天的含2-AAF饮食处理后,体内DNA复制被抑制到检测水平以下。2-AAF诱导的生长抑制伴随着表皮生长因子(EGF)结合位点数量的下调以及EGFR转录本水平的降低,而转化生长因子-α(TGF-α)mRNA水平未观察到变化。通过间歇性给予2-AAF产生的持续性肝结节,其复制细胞比例比正常肝脏高30至35倍。在2-AAF处理14天后,体内给予2-AAF可使结节中的复制细胞比例降至三分之一。在给予2-AAF之前,结节中初始的EGFR mRNA水平和EGF结合位点数量约为对照肝脏的605倍,并因给予2-AAF而略有降低。因此,在给予2-AAF 14天后,结节中和经2-AAF处理的对照肝脏中的EGFR mRNA水平相似,而在2-AAF处理后,结节中增殖细胞的比例远高于正常肝脏。发现结节中的TGF-α mRNA水平是正常肝脏的1.4倍,在恶性肝癌中是正常肝脏的1.7倍。从对照肝脏分离的原代肝细胞对EGF复制刺激的敏感性比对TGF-α高4至5倍,而结节细胞在较低浓度下就有反应,并且对EGF和TGF-α的反应相同。我们得出结论,与增殖刺激相关的结节细胞中EGFR数量的减少,可能被TGF-α合成增加以及TGF-α敏感性增加所弥补。总体而言,这些变化表明TGF-α在化学诱导的大鼠肝癌发生过程中维持细胞增殖。